A Novel Method for the Synthesis of (99m)Tc-Ofloxacin Kits Using D-Penicillamine as Coligand and Their Application as Infection Imaging Agent.
Muhammad Abdul QadirShabnam ShahzadRashid RasheedMahmood AhmedShahzad AnwarSyeda Kiran ShahzadiPublished in: BioMed research international (2015)
The employment of radiopharmaceuticals is increasing nowadays for infection imaging and early execution of patients having infectious or inflammatory complaints. The main aim of this study was to discover a novel method for the labeling of ofloxacin with (99m)Tc, optimization of labelling conditions to get higher percent yield, to assess kits radiochemical purity, in vitro stability, partition coefficient, protein binding, and intracellular accumulation in Pseudomonas aeruginosa, Salmonella typhi, and Escherichia coli in infected rabbits. Maximum labeling efficiency was achieved when 1.5 mg ofloxacin was labeled with 10-20 mCi sodium pertechnetate in the presence of 3 mg D-penicillamine, 75 μg SnCl₂. In vitro binding and biodistribution in Pseudomonas aeruginosa, Salmonella typhi, and Escherichia coli showed good results. This new complex is efficient for the imaging of infections caused by Gram-positive and Gram-negative bacteria.
Keyphrases
- escherichia coli
- pseudomonas aeruginosa
- high resolution
- biofilm formation
- cystic fibrosis
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- magnetic resonance imaging
- binding protein
- computed tomography
- mass spectrometry
- magnetic resonance
- prognostic factors
- staphylococcus aureus
- gram negative
- fluorescence imaging
- photodynamic therapy
- multidrug resistant
- transcription factor
- patient reported outcomes
- positron emission tomography